IRVINE, Calif., Oct. 9, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced the FDA 510(k) clearance and market release of Masimo's new uSpO 2 ™ universal pulse oximetry cable for use with GE ...
More than a decade into their partnership, Masimo and GE HealthCare are still finding new ways to combine their respective patient monitoring technologies. In the latest expansion of their ...
CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo Signal Extraction Technology® (SET®) pulse ...
GE Healthcare and Masimo have announced a joint agreement to integrate Masimo’s Signal Extraction Technology (SET) pulse oximetry into GE’s Portrait Mobile wireless and wearable patient monitoring ...
"Combining Masimo's measurements advances with our innovative patient monitors enhances bedside clinical decision-making and ultimately, supports patient care," said Matthias Weber, General Manager of ...
Masimo's uSpO 2 ™ (pictured) is a "Board-in-Cable" external pulse oximetry solution that provides a simple way to add Masimo SET ® pulse oximetry for devices that are not designed to have SpO 2 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results